Uncovering the Gut–Liver Axis Biomarkers for Predicting Metabolic Burden in Mice
Open Access
Abstract
Western diet (WD) intake, aging, and inactivation of farnesoid X receptor (FXR) are risk factors for metabolic and chronic inflammation-related health issues ranging from metabolic dysfunction-associated steatotic liver disease (MASLD) to dementia. The progression of MASLD can be escalated when those risks are combined. Inactivation of FXR, the receptor for bile acid (BA), is cancer prone in both humans and mice. The current study used multi-omics including hepatic transcripts, liver, serum, and urine metabolites, hepatic BAs, as well as gut microbiota from mouse models to classify those risks using machine learning. A linear support vector machine with K-fold cross-validation was used for classification and feature selection. We have identified that increased urine sucrose alone achieved 91% accuracy in predicting WD intake. Hepatic lithocholic acid and serum pyruvate had 100% and 95% accuracy, respectively, to classify age. Urine metabolites (decreased creatinine and taurine as well as increased succinate) or increased gut bacteria (Dorea, Dehalobacterium, and Oscillospira) could predict FXR deactivation with greater than 90% accuracy. Human disease relevance is partly revealed using the metabolite–disease interaction network. Transcriptomics data were also compared with the human liver disease datasets. WD-reduced hepatic Cyp39a1 (cytochrome P450 family 39 subfamily a member 1) and increased Gramd1b (GRAM domain containing 1B) were also changed in human liver cancer and metabolic liver disease, respectively. Together, our data contribute to the identification of noninvasive biomarkers within the gut–liver axis to predict metabolic status.Keywords
Funding Information
- National Institutes of Health (U01CA179582 and R01CA222490, P30AG010129, H 18-10925-0 and 22-10079)
- NIH National Institute on Aging Grants (U01CA179582 and R01CA222490, P30AG010129, H 18-10925-0 and 22-10079)
- California Department of Public Health, Chronic Disease Control Branch, Alzheimer’s Disease Program (U01CA179582 and R01CA222490, P30AG010129, H 18-10925-0 and 22-10079)
This publication has 114 references indexed in Scilit:
- Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinomaAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Hepatocarcinogenesis in FXR−/− Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR ExpressionMolecular Endocrinology, 2012
- Influence of Urine Creatinine on the Relationship between the Albumin-to-Creatinine Ratio and Cardiovascular EventsClinical Journal of the American Society of Nephrology, 2012
- Zip4 (Slc39a4) Expression is Activated in Hepatocellular Carcinomas and Functions to Repress Apoptosis, Enhance Cell Cycle and Increase MigrationPLOS ONE, 2010
- Spontaneous hepatocarcinogenesis in farnesoid X receptor-null miceCarcinogenesis, 2006
- Identification of 9-Hydroxyoctadecadienoic Acid and Other Oxidized Free Fatty Acids as Ligands of the G Protein-coupled Receptor G2AJournal of Biological Chemistry, 2005
- Novel SLC39A4 Mutations in Acrodermatitis EnteropathicaJournal of Investigative Dermatology, 2003
- A Novel Member of a Zinc Transporter Family Is Defective in Acrodermatitis EnteropathicaThe American Journal of Human Genetics, 2002
- Identification of SLC39A4, a gene involved in acrodermatitis enteropathicaNature Genetics, 2002
- Support vector machinesIEEE Intelligent Systems and their Applications, 1998